Detalhe da pesquisa
1.
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
Int J Cancer
; 154(10): 1760-1771, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38296842
2.
BRAF/MEK inhibitor rechallenge in advanced melanoma patients.
Cancer
; 130(9): 1673-1683, 2024 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38198485
3.
Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.
Int J Cancer
; 153(2): 389-398, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843260
4.
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
Int J Cancer
; 152(12): 2493-2502, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36843274
5.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36203067
6.
Patient-Reported Outcomes of Medical Tattooing for Capillary Malformations.
Dermatology
; 239(5): 768-781, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37442102
7.
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.
Int J Cancer
; 150(5): 816-824, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34605003
8.
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 587-588, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36319872
9.
Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.
EClinicalMedicine
; 69: 102485, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38370537
10.
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.
Cancers (Basel)
; 15(2)2023 Jan 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36672358
11.
Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.
Eur J Cancer
; 186: 27-37, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37023588
12.
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
Cancers (Basel)
; 15(11)2023 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37296885
13.
[Medical tattooing, an unknown treatment option]. / Medisch tatoeëren, een onbekende behandeloptie.
Ned Tijdschr Geneeskd
; 1662022 05 12.
Artigo
Holandês
| MEDLINE | ID: mdl-35736376
14.
BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma.
JCO Precis Oncol
; 6: e2200018, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-36130145
15.
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma.
JAMA Oncol
; 8(12): 1794-1801, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36301521
16.
Response to immune checkpoint inhibitors in acral melanoma: A nationwide cohort study.
Eur J Cancer
; 167: 70-80, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35395553
17.
Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
Eur J Cancer
; 158: 234-245, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34600790
18.
Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events-Reply.
JAMA Oncol
; 9(5): 724, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36892850
19.
Response to letter Re: Response to checkpoint inhibition and targeted therapy in melanoma patients with concurrent haematological malignancies.
Eur J Cancer
; 191: 112983, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37537090